Aldevron, a leading provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announce the appointment of James Brown, Ph.D., as Vice President, Corporate Development. Dr. Brown’s responsibilities include developing and implementing strategies for expanding Aldevron’s DNA, mRNA, antibody, and protein products and production services.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160127006255/en/

Dr. James Brown, Aldevron Vice President of Corporate Development (Photo: Business Wire)

Dr. James Brown, Aldevron Vice President of Corporate Development (Photo: Business Wire)

“We are pleased to add James to our executive leadership team during this time of rapid growth for our company and industry,” said Michael Chambers, President and CEO. “James has more than 20 years’ experience in the biotechnology industry and has been a key player in the successful growth of several organizations. His broad background in partnership development, biologics manufacturing, vendor and client management, and operations will be invaluable as we focus on serving our clients in their efforts to develop the next generation of biological treatments for some of the most challenging diseases.”

Dr. Brown most recently served as VP, Technical Operations at REGENXBIO Inc., a leading gene therapy company. In this role he was responsible for managing manufacturing, vendor relationships, operations, quality assurance, and biological reagent sales. Prior to REGENXBIO Dr. Brown was Director of Relationship Management at MedImmune, where he managed information technologies and services for research and development. Earlier in his career, he served in roles of increasing responsibility in information technology and quality assurance at Meso Scale Discovery and IGEN International, Inc.

“I look forward to collaborating with my colleagues and the world-class companies with whom we work to provide them with the high quality products and services they require to create transformative therapies,” said Dr. Brown.

Dr. Brown holds a Ph.D. in Chemistry from Stanford University and a B.S. in Chemistry from Butler University.

About Aldevron

Aldevron offers development services and custom manufacturing of nucleic acids, proteins and antibodies, providing companies with essential components for research, clinical and commercial applications. Aldevron’s services include GMP-Source™ and GMP plasmid manufacturing, linear DNA and mRNA production, gene synthesis, RNA synthesis enzymes, and humanized and recombinant antibody generation. Aldevron’s collaborative approach and commitment to providing quality materials allow them to meet precise client requirements and provide innovative solutions to advance science. Aldevron is headquartered in Fargo, North Dakota, and has facilities in Madison, Wisconsin, and Freiburg, Germany.